1. Home
  2. AAPG vs VEON Comparison

AAPG vs VEON Comparison

Compare AAPG & VEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • VEON
  • Stock Information
  • Founded
  • AAPG 2009
  • VEON 1992
  • Country
  • AAPG China
  • VEON United Arab Emirates
  • Employees
  • AAPG N/A
  • VEON N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • VEON Telecommunications Equipment
  • Sector
  • AAPG Health Care
  • VEON Telecommunications
  • Exchange
  • AAPG Nasdaq
  • VEON Nasdaq
  • Market Cap
  • AAPG 3.2B
  • VEON 2.7B
  • IPO Year
  • AAPG 2025
  • VEON 1996
  • Fundamental
  • Price
  • AAPG $38.24
  • VEON $49.39
  • Analyst Decision
  • AAPG Buy
  • VEON Strong Buy
  • Analyst Count
  • AAPG 1
  • VEON 1
  • Target Price
  • AAPG N/A
  • VEON $60.00
  • AVG Volume (30 Days)
  • AAPG 12.4K
  • VEON 316.2K
  • Earning Date
  • AAPG 08-06-2025
  • VEON 08-07-2025
  • Dividend Yield
  • AAPG N/A
  • VEON N/A
  • EPS Growth
  • AAPG N/A
  • VEON N/A
  • EPS
  • AAPG N/A
  • VEON 6.56
  • Revenue
  • AAPG $134,352,180.00
  • VEON $4,088,000,000.00
  • Revenue This Year
  • AAPG N/A
  • VEON $6.27
  • Revenue Next Year
  • AAPG $389.09
  • VEON $6.79
  • P/E Ratio
  • AAPG N/A
  • VEON $6.94
  • Revenue Growth
  • AAPG 341.77
  • VEON 8.84
  • 52 Week Low
  • AAPG $16.50
  • VEON $25.83
  • 52 Week High
  • AAPG $43.58
  • VEON $59.68
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • VEON 60.22
  • Support Level
  • AAPG N/A
  • VEON $42.54
  • Resistance Level
  • AAPG N/A
  • VEON $46.81
  • Average True Range (ATR)
  • AAPG 0.00
  • VEON 2.75
  • MACD
  • AAPG 0.00
  • VEON 0.83
  • Stochastic Oscillator
  • AAPG 0.00
  • VEON 52.27

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About VEON VEON Ltd. ADS

VEON Ltd is a United Arab Emirates-based digital operator providing connectivity and Internet services to corporations and individuals. The company offers mobile and fixed-line telecommunications services through a range of traditional and broadband mobile technologies. The company's reportable segments consist of the following five segments: Pakistan, Ukraine, Kazakhstan, Bangladesh, and Uzbekistan. It provides its services under the Beeline, Kyivstar, Banglalink, and Jazz brands. It generates the majority of its revenue from Pakistan.

Share on Social Networks: